All news

Quoin shareholders lift ownership cap to 9.99%

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Quoin Pharmaceuticals shareholders approved an amendment raising beneficial ownership limits for investors in recent private placements from 4.99% to 9.99%, decided at a Special General Meeting. The company faces financial challenges, with shares down significantly over the past year. Canaccord Genuity and BTIG initiated buy ratings, citing lead rare dermatology program QRX003 for Netherton syndrome.

Read original source

QNRX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.